Long-Term Clinical Outcomes Following the WATCHMAN Device Use in Medicare Beneficiaries.

ABSTRACT:

Background

Long-term outcomes following left atrial appendage occlusion outside clinical trials and small registries are largely unknown. Collecting these data was a condition of US market authorization of the WATCHMAN device. The aim of this analysis was to evaluate the rates of stroke, bleeding, and death among Medicare beneficiaries following left atrial appendage occlusion implantation during initial commercial availability of the WATCHMAN left atrial appendage occlusion device overall and in important subgroups.

Methods

All Medicare fee-for-service beneficiaries ≥65 years of age who underwent left atrial appendage occlusion from April 1, 2016, to August 31, 2020, were included based on the International Classification of Diseases, Tenth Revision, and Current Proc

SUBMITTER: Zeitler EP 

PROVIDER: S-EPMC11485207 | biostudies-literature | 2024 Oct

REPOSITORIES: biostudies-literature